Atlas Trials

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

Clinical trial NCT04014374 · RECRUITING

Trial details

NCT number
NCT04014374
Sponsor
Kyowa Kirin, Inc.
Status
RECRUITING
Study type
OBSERVATIONAL
Leukemia/LymphomaCutaneous T Cell LymphomaATLL
Start date
2019-09-10
Primary completion
2030-02-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.